A limitation of our study was that only 5 patients had documented seroconversion for CHIKV. However, high titers were found in all but 1 patient (>1,280 in 21 patients and 640 in 2 patients). This patient, who had a titer of 80, was an Italian who had probably not been previously exposed to CHIKV. Thus, the risk for misclassifi cation was low. PCR for early detection of infection was not used because only 3 persons were tested within 10 days of symptom onset. Two of these persons, who were tested 7 days after symptom onset, already had antibodies to CHIKV.
In conclusion, a high proportion of travelers with symptoms of CHIKV infection who returned from areas with outbreaks of this infection or where this virus was endemic were seropositive. A lower proportion of patients had antibodies to DENV. CHIKV-positive patients were more likely to have a rash than those negative for both CHIKV and DENV. As suggested by previous studies (9) , a rash was more common among CHIKV-positive patients than in DENV-infected patients, but the difference was not signifi cant. Our study suggests that identifi cation of predictors of infection with CHIKV is feasible, although it is complicated by cocirculation of DENV in the same areas.
Acinetobacter spp. in Gunshot Injuries
To the Editor: Challenges posed by Acinetobacter spp. result from multidrug resistance, nosocomial spread, and hospital-wide outbreaks (1-3). We evaluated Acinetobacter spp. infections from gunshot injuries received during the April 2006 East Timor confl ict (for a description of these events and further reading, see http://en.wikipedia.org/wiki/2006_ East_Timorese_crisis).
We reviewed records of 15 injured East Timorese police offi cers. Median age was 29 years (range 25-45 years); 13 were male. Typical injuries were from multiple high-velocity gunshots and shrapnel. All patients had undergone surgery for stabilization and wound debridement before evacuation to the Royal Darwin Hospital (RDH) in Australia; most had likely received antimicrobial drugs including ampicillin, gentamicin, metronidazole, and ceftriaxone. They arrived at RDH a median of 3 days after injury (range 2-12 days).
The patients were separated from other hospital inpatients on arrival; they were managed as a cohort, they had dedicated nursing staff, and barrier contact precautions were practiced. However, the patients were not routinely screened for colonization with microbiologic organisms. Additional surgical management, including further wound debridement, was performed on 12 of the 15 patients (11 within 48 hours of arrival at RDH); intraoperative samples of bone, soft tissue, and wounds were submitted for culture.
From 13 patients (including all 11 with gunshot wounds), 19 Acinetobacter spp. isolates were recovered. Acinetobacter spp. was cultured from deep wound tissue obtained during surgery from 9 patients. Substantial antimicrobial drug resistance was demonstrated by automated testing (Vitek 2, bioMérieux, Marcy l'Etoile, France) (Table) . All 19 Acinetobacter spp. isolates were classifi ed as multidrug resistant (resistant to >3 drug classes) (4). Isolates from 10 of the 13 culture-positive patients (12 of 19 isolates) were resistant to all tested drugs except meropenem and amikacin. Susceptibility testing for tigecycline and tetracycline was not performed. No isolate was metallo-β-lactamase positive by phenotypic analysis according to tablet disk diffusion method using imipenem and imipenem plus EDTA Neo-Sensitabs (Rosco Diagnostica, Taastrup, Denmark On the basis of clinical assessment by the treating surgeon and infectious diseases physician, 11 patients were treated for Acinetobacter spp. infection. Patients 1-5 had comminuted compound fractures associated with intraoperative deep wound tissue that was culture positive for Acinetobacter spp. and were treated for osteomyelitis; patients 6-11 were treated for wound infections; patients 6-8 had intraoperative deep wound tissue culture positive for Acinetobacter spp.; patients 9-10 had superfi cial wound swabs that were culture positive; and patient 11 had a positive culture from a nonsurgical site. Of these 11 patients, 4 had fever >38°C on the day of admission to RDH (2 of whom had a leukocyte count >20,000/μL), and another 2 had visible pus, necrotic tissue, or both. The surgical approach to these patients involved delayed wound closure; fracture fi xation; vacuum dressings; and skin, bone, and nerve grafts. Choice and duration of antimicrobial drug therapy was guided by susceptibility testing and experience (4) . Presumed osteomyelitis caused by multidrug-resistant (MDR) Acinetobacter spp. was treated with meropenem in combination with amikacin for at least 2 weeks, followed by another 2 weeks of meropenem monotherapy. Wound infections were similarly treated with combination therapy initially, but amikacin was stopped earlier. No aminoglycoside toxicity was observed. Treatment was stopped at 4 weeks if no signs of infection were present (healed wound plus apyrexia and a C-reactive protein level <20 mg/L). Patient 12 was colonized with MDR Acinetobacter spp. and was treated for aspiration pneumonia; patient 13 had MDR Acinetobacter spp. colonization of a central venous catheter.
Follow-up after completion of therapy ranged from 4 to 23 weeks. No patients had recurrence of infection or isolation of Acinetobacter spp. Defi ning osteomyelitis and wound infection caused by Acinetobacter spp. was problematic for clinicians (4) (5) (6) , and some assumed infections may have represented colonization. Because treatment for MDR Acinetobacter spp. in this setting can be protracted and toxic (e.g., from aminoglycosides), our review highlights the potential benefi ts of applying prospectively documented criteria such as abnormal bone histologic fi ndings for osteomyelitis and a workable defi nition of deep tissue infection to better guide treatment decisions.
RDH had not experienced outbreaks of healthcare-associated infection or colonization with MDR Acinetobacter spp. before or after (as of To the Editor: Varicose vein sclerotherapy is a commonly performed cosmetic surgical procedure in which a sclerosing agent is injected into small varicose veins of the leg by using small gauge needles. It is regarded as a minor, safe procedure, usually performed in an offi ce clinic (1). We describe a cluster of infections with group A Streptococcus spp. associated with throat carriage in a cosmetic surgeon.
In early December 2006, 3 patients were seen over a 10-day period at Geelong Hospital with infections following varicose vein sclerotherapy. All patients had undergone varicose vein sclerotherapy with polidocanol (Laurath-9; Aethoxysklerol, BSN Medical, Mount Waverley, Victoria, Australia) at a clinic of a single cosmetic surgeon. The index patient (patient A) had toxic shock syndrome and necrotizing fasciitis of the treated legs. The 2 other patients (patients C and D) had multifocal cellulitis directly correlating to the injection sites. The time between sclerotherapy and disease onset was 1-2 days.
A case-patient was defi ned as a patient who had undergone sclerotherapy at the clinic and subsequently had infection directly related to the site of sclerosant injection. Events were dated from the day on which the index patient had her surgical procedure. We reviewed clinic notes and infection control procedures in conjunction with the Department of Human Services of the State Government of Victoria, Australia. Specimens, where available, were collected for culture from patients by the treating clinicians. A throat swab was taken from the cosmetic surgeon. Specimens were transported and cultured by using standard methods.
During the outbreak period, 44 patients had vein sclerotherapy with 3% polidocanol at the cosmetic surgeon's clinic. In addition to the 3 patients identifi ed on admission to hospital, a fourth patient (patient B) sought treatment from her general practitioner for medical care for a postprocedure infection. All patients had procedures on day 1 or day 7 (Figure) ; patients A and B were seen consecutively on day 1, and 2 patients were treated between patients C and D on day 7.
Patient A required surgical debridement, intravenous antimicrobial drugs, intensive care, and hyperbaric oxygen therapy. Intraoperative specimens taken from her during debridement cultured group A Streptococcus spp. Patients B, C, and D had cellulitis, but no specimens suitable for microbiologic diagnosis of cellulitis were taken for culture. Patient B was treated with oral antimicrobial agents as an outpatient. Patient C was admitted to hospital for intravenous antimicrobial therapy, and patient D showed no improvement on oral antimicrobial therapy as an outpatient and was subsequently admitted to hospital for intravenous antimicrobial agents.
Group A Streptococcus spp. was isolated from a throat swab taken on day 16 from the cosmetic surgeon. He reported no upper respiratory tract infection symptoms before the outbreak. He also reported that antiseptic skin preparation was not routinely used during the procedures; nor were gloves used. However, alcohol hand rubs were used between patients. The surgeon had not changed his infection control procedures recently and had not been aware of any infective complications previously. Environmental surface swabs taken on day 14 from 3 different areas (procedural trolley, surgical spotlight, and examination couch) in the clinic during the assessment yielded no pathogenic organisms. The infection control assessment team noted overall cleaning, disinfection, and hand hygiene to be inadequate.
Decolonization of the surgeon was performed by using rifampin 600 mg daily and amoxicillin 500 
